Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

FDA approves Praluent to reduce risk of heart attack, stroke and unstable angina

April 29, 2019

ANGPTL2 knockdown results in mouse model of spontaneous aortic valve stenosis

April 26, 2019

Development of novel hamster-L5 model to investigate pathophysiology of atherosclerosis

April 25, 2019

Positive results presented from phase II/III TAZPOWER study of elamipretide

April 17, 2019

Positive interim results presented from phase I study of CERC-301

April 16, 2019

Sorrento Therapeutics expands clinical development program for resiniferatoxin

April 15, 2019

Fully human stem cells show heart muscle regeneration promise

April 9, 2019

United Therapeutics discontinues development of esuberaprost based on BEAT results in PAH

April 8, 2019

Stem cell-derived human 'hearts' identify new cardiac drugs

April 4, 2019

Repair enables regeneration for blood vessels

April 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...